Anti‐BP230‐type papular non‐bullous pemphigoid with granular immunoglobulin G deposition at the papillary dermis
Anti‐BP230‐type papular non‐bullous pemphigoid with granular immunoglobulin G deposition at the papillary dermis
复制标题
抗 BP230 型丘疹性非大疱性类天疱疮,真皮乳头层有颗粒状免疫球蛋白 G 沉积
DOI:
10.1111/1346-8138.16070
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Ishii Norito
中科院分区:
文献类型:
--
作者:
Dainichi Teruki;Kaku Yo;Izumi Maiko;Kataoka Koki;Morishita Yoshiko;Koga Hiroshi;Ishii Norito
Around 5% of the bullous pemphigoid (BP) patients’ sera react with BP230 only. 1 Anti-BP230-type BP generally show lower severity, and possibly with focal involvement. 2 The pathogenic involvement of anti-BP230 IgG antibodies in BP remains controversial3, 4 because BP230 is an intracellular plakin protein. We report a case of anti-BP230-type BP that exhibited generalized pruritic papules and plaques with granular IgG deposition in the papillary dermis. A woman in her 50s presented with generalized pruritic erythematous papules and plaques over her body. She had developed blisters three years prior. Skin biopsy revealed subepidermal blistering and C3 deposition in the basement membrane zone (BMZ). The serum titer of the BP180 IgG autoantibodies was 170 U/mL. The patient was diagnosed with BP and treated with prednisolone (40 mg/day). The blisters disappeared, and serum BP180 IgG antibodies became negative. Systemic corticosteroids were tapered off; however, gradually, the reddish papules recurred. These papules were treated with methylprednisolone 24 mg, mizoribine 150 mg, diaphenylsulfone 75 mg daily, and topical diflorasone diacetate. On examination, red-to-brown, shiny, flat-topped papules and plaques were scattered on the trunk and extremities (Figure 1a). Laboratory examination revealed 11,210/mm3 blood leukocytes, 620/mm3 lymphocytes, 170/mm3 eosinophils, 0.03 mg/dL